Introduction Following widespread exposure to Omicron variants, SARS-CoV-2 has transitioned to endemic circulation.
Pharma R&D faces rising trial complexity, high costs, and patient and investigator shortages, driving the need for adaptive models and data-driven strategies to speed therapies to market.
The Bank of Canada’s decision to lower interest rates for the first time since March will have a direct effect on variable mortgages, and shifts the equation on whether to go with a fixed or variable ...
In this video interview, Ananth Kadambi, VP of real-world evidence and modeling solutions at Certara, explains how integrating real-world evidence and predictive modeling early in development can ...
Building exceedance probability curves isn’t just for simulating the potential impact of hurricanes; they can be used to plot ...
“Companies are investing in the areas of AI that are demonstrating near-term results but also experimenting with a broader range of use cases,” said Steve Hall, Chief AI Officer, ISG. “The variety of ...